126 related articles for article (PubMed ID: 16054573)
21. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
22. [Prevention and management of appetite loss during cancer chemotherapy].
Tsujimura H; Yamada M; Asako E; Kodama Y; Sato T; Nabeya Y
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1191-5. PubMed ID: 25335699
[TBL] [Abstract][Full Text] [Related]
23. The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants.
Gralla RJ; Roila F; Tonato M; ; ; ; ; ; ; ; ;
Support Care Cancer; 2005 Feb; 13(2):77-9. PubMed ID: 15605253
[No Abstract] [Full Text] [Related]
24. Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients.
Dupuis LL; Boodhan S; Holdsworth M; Robinson PD; Hain R; Portwine C; O'Shaughnessy E; Sung L;
Pediatr Blood Cancer; 2013 Jul; 60(7):1073-82. PubMed ID: 23512831
[TBL] [Abstract][Full Text] [Related]
25. Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting.
Schwartzberg LS; Grunberg SM; Kris MG
Clin Adv Hematol Oncol; 2011 Nov; 9(11 Suppl 27):1-14; quiz 15-6. PubMed ID: 22362372
[TBL] [Abstract][Full Text] [Related]
26. Which physician and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders?
Smolders M; Laurant M; Verhaak P; Prins M; van Marwijk H; Penninx B; Wensing M; Grol R
Med Care; 2010 Mar; 48(3):240-8. PubMed ID: 20125045
[TBL] [Abstract][Full Text] [Related]
27. Antiemetics for children with gastroenteritis: off-label but still on in clinical practice.
Albano F; Bruzzese E; Spagnuolo MI; De Marco G
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):402-4. PubMed ID: 16954969
[TBL] [Abstract][Full Text] [Related]
28. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?
Antonarakis ES; Evans JL; Heard GF; Noonan LM; Pizer BL; Hain RD
Pediatr Blood Cancer; 2004 Nov; 43(6):651-8. PubMed ID: 15390297
[TBL] [Abstract][Full Text] [Related]
29. NCCN antiemesis guidelines emphasize 'delayed' emesis, new 5-HT3 inhibitors, and NK-1 blockers.
National Comprehensive Cancer Network (NCCN)
J Support Oncol; 2004; 2(4):366. PubMed ID: 15357520
[No Abstract] [Full Text] [Related]
30. Do we need new antiemetic guidelines?
Roila F
Support Care Cancer; 2002 Oct; 10(7):517-8. PubMed ID: 12324804
[No Abstract] [Full Text] [Related]
31. Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference.
Roila F; Hesketh PJ; Herrstedt J;
Ann Oncol; 2006 Jan; 17(1):20-8. PubMed ID: 16314401
[TBL] [Abstract][Full Text] [Related]
32. Awareness of, opinions about, and adherence to evidence-based guidelines in otorhinolaryngology.
Aarts MC; van der Heijden GJ; Siegers C; Grolman W; Rovers MM
Arch Otolaryngol Head Neck Surg; 2012 Feb; 138(2):148-52. PubMed ID: 22351860
[TBL] [Abstract][Full Text] [Related]
33. The efficacy and cost effectiveness of new antiemetic guidelines.
Engstrom C; Hernandez I; Haywood J; Lilenbaum R
Oncol Nurs Forum; 1999 Oct; 26(9):1453-8. PubMed ID: 11064877
[TBL] [Abstract][Full Text] [Related]
34. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
Trigg ME; Inverso DM
Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
[TBL] [Abstract][Full Text] [Related]
35. Neurokinin-1-receptor antagonists: a new approach in antiemetic therapy.
Jordan K
Onkologie; 2006 Feb; 29(1-2):39-43. PubMed ID: 16514255
[TBL] [Abstract][Full Text] [Related]
36. Ongoing provision of individual clinician performance data improves practice behavior.
Frenzel JC; Kee SS; Ensor JE; Riedel BJ; Ruiz JR
Anesth Analg; 2010 Aug; 111(2):515-9. PubMed ID: 20529985
[TBL] [Abstract][Full Text] [Related]
37. Multinational Association of Supportive Cancer Care (MASCC).
Roila F;
Support Care Cancer; 2003 Apr; 11(4):260-1. PubMed ID: 12749339
[No Abstract] [Full Text] [Related]
38. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
Jordan K; Voigt W; Schmoll HJ
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
[TBL] [Abstract][Full Text] [Related]
39. Antiemetic effectiveness and nausea and vomiting incidence during capecitabine and oxaliplatin chemotherapy.
Chan A; Tan SH; Low XH; Yap KY
Nurs Res; 2012; 61(6):405-12. PubMed ID: 22960588
[TBL] [Abstract][Full Text] [Related]
40. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics.
Viale PH
Clin J Oncol Nurs; 2005 Feb; 9(1):77-84. PubMed ID: 15751501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
